Biggest News Aggregation in the World
📰 Multi Regional News

Multi Regional News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Multi Regional. Real-time updates on events, politics, business and more.

HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies

HanchorBio Inc., a global clinical-stage biotechnology company developing innovative immuno-biomedicines, announced today that the Taiwan Food and Drug Administration (TFDA) has approved its investigational new drug (IND) application to initiate a multi-regional clinical trial of its independently-developed novel drug candidate, HCB101, for the treatment of patients with advanced solid tumors or relapsed and refractory non-Hodgkin lymphoma.
United States T Ai Pei Sean Juo Scott Liu Dora Weng Chief Executive Officer
Source: yahoo.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science